HFE C282Y is a risk factor for hepatic veno-occlusive disease (HVOD) and carbamyl-phosphate synthetase (CPS) polymorphisms may counteract its adverse effects. Bone Marrow Transplant. 2005 April 18.
« Go Back
Your Name:
Your Email/URL (Optional):
Your Comment:
Comment Guidelines: No HTML is allowed. Off-topic or inappropriate comments will be edited or deleted. Thanks.